Vitalux-S
Natural health product licensed in Canada
- Licence holder
- Nutricorp International
- NPN or DIN-HM
- 80015728
- Status
- Inactive licence
- Licence date
- 5 February 2010
- Revision date
- 16 September 2010
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine C: up to 500 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 180 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine C Source : Acide ascorbique | 250 mg | 500,000 µg |
Non-medicinal ingredients
Hypromellose, Poly(éthylène glycol), Cellulose, microcristalline, Stéarate de magnésium végétal, Dioxyde de titane, Colorant caramel, Calcium Silicate, Ethyl Vanillin, Poly(sorbate) 80, Acide stéarique, Hydroxypropylcellulose, Cire de carnauba, Xanthan Powder, Diacetylated Monoglycerides NF
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 50 years | 1 Comprimé | 2 Tous les jours |
Uses authorised in Canada
An eye vitamin/mineral supplement that helps reduce the risk of the development of advanced age related macular degeneration in high-risk individuals. Also contains Lutein and Zeaxanthin, which help to reduce the risk of decreased visual acuity associated with advanced age related macular degeneration.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80015728
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2010. Photograph the packaging to check whether it has changed. Photograph the packaging